We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-27.19%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$7.34B
AUM Growth
-$3.86B
Cap. Flow
-$375M
Cap. Flow %
-5.12%
Top 10 Hldgs %
9.89%
Holding
1,223
New
86
Increased
388
Reduced
436
Closed
75

Top Buys

Rank Stock Value
1
ESE icon
ESCO Technologies
ESE
+$40.8M
2
HAE icon
Haemonetics
HAE
+$37.6M
3
ROG icon
Rogers Corp
ROG
+$26.2M
4
EVR icon
Evercore
EVR
+$25.5M
5
FARO
Faro Technologies
FARO
+$22M

Sector Composition

Rank Sector Weight
1 Industrials 25.72%
2 Technology 19.64%
3 Financials 14.17%
4 Consumer Discretionary 10.37%
5 Healthcare 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRIM icon
301
Primoris Services
PRIM
$4.58B
$6.56M 0.09%
412,480
+45,000
+12% +$877K
CNTY icon
302
Century Casinos
CNTY
$34M
$6.56M 0.09%
2,720,162
-10,100
-0.4% -$65.5K
CSFL
303
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$6.53M 0.09%
379,137
-120,500
-24% -$2.61M
FEIM icon
304
Frequency Electronics
FEIM
$635M
$6.5M 0.09%
711,624
UTI icon
305
Universal Technical Institute
UTI
$2.16B
$6.45M 0.09%
1,084,032
+135,000
+14% +$956K
RMR icon
306
The RMR Group
RMR
$325M
$6.44M 0.09%
238,907
+97,766
+69% +$3.79M
AHRT
307
AH Realty Trust
AHRT
$529M
$6.43M 0.09%
601,001
+105,700
+21% +$1.71M
OOMA icon
308
Ooma
OOMA
$598M
$6.41M 0.09%
537,446
-5,000
-0.9% -$63.2K
ALB icon
309
Albemarle
ALB
$13.9B
$6.4M 0.09%
113,591
+21,356
+23% +$1.64M
KRA
310
DELISTED
Kraton Corporation
KRA
$6.4M 0.09%
790,460
+163,816
+26% +$2.44M
WIRE
311
DELISTED
Encore Wire Corp
WIRE
$6.35M 0.09%
151,278
+8,074
+6% +$417K
SRI icon
312
Stoneridge
SRI
$195M
$6.31M 0.09%
376,569
-170,480
-31% -$4.23M
HGV icon
313
Hilton Grand Vacations
HGV
$3.59B
$6.3M 0.09%
399,334
-33,098
-8% -$909K
HP icon
314
Helmerich & Payne
HP
$3.45B
$6.22M 0.08%
397,553
-125,049
-24% -$4.4M
ESTC icon
315
Elastic
ESTC
$6.84B
$6.18M 0.08%
+110,800
New +$7.16M
NEO icon
316
NeoGenomics
NEO
$1.96B
$6.18M 0.08%
223,683
-36,800
-14% -$1.1M
TGP
317
DELISTED
Teekay LNG Partners L.P.
TGP
$6.13M 0.08%
626,661
-26,900
-4% -$332K
RDN icon
318
Radian Group
RDN
$5.18B
$6.11M 0.08%
471,559
-5,000
-1% -$109K
TTMI icon
319
TTM Technologies
TTMI
$12B
$6.06M 0.08%
586,117
+18,887
+3% +$248K
CEMI
320
DELISTED
Chembio diagnostics, Inc.
CEMI
$6.02M 0.08%
1,175,316
+183,824
+19% +$744K
CVCO icon
321
Cavco Industries
CVCO
$4.22B
$6M 0.08%
41,400
+8,100
+24% +$1.59M
CLF icon
322
Cleveland-Cliffs
CLF
$6.57B
$5.98M 0.08%
1,513,087
-22,403
-1% -$141K
ELF icon
323
e.l.f. Beauty
ELF
$4.89B
$5.97M 0.08%
+607,000
New +$9.11M
SNEX icon
324
StoneX
SNEX
$9.26B
$5.95M 0.08%
830,235
PDFS icon
325
PDF Solutions
PDFS
$1.93B
$5.93M 0.08%
506,200

Similar funds

Royce & Associates's Q1 2020 Portfolio in Review

As of Q1 2020, Royce & Associates held 1,223 positions worth $7.34B, down 34% from $11.2B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Royce & Associates withdrew a net $375M in Q1 2020, closing 75 positions and reducing 436 holdings. Its most notable exit was AVX Corporation, an estimated $71.1M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in ESCO Technologies worth $33.9M.

  • Royce & Associates's largest Q1 2020 buy was ESCO Technologies: 447,118 shares worth $33.9M.
  • Royce & Associates added most to Haemonetics in Q1 2020, an estimated $37.6M increase.
  • Royce & Associates's biggest Q1 2020 reduction was Virtu Financial, cutting an estimated $51M.
  • Royce & Associates fully exited AVX Corporation in Q1 2020, selling an estimated $71.1M.
  • Royce & Associates's ten largest holdings make up 9.9% of its $7.34B portfolio in Q1 2020.
  • Royce & Associates opened 86 new positions and closed 75 in Q1 2020.
  • Royce & Associates's portfolio value fell 34% quarter-over-quarter to $7.34B.

Based on Royce & Associates's 13F filing for Q1 2020, filed 12 May 2020.